decreases with A, with a maximum decrease of 37.84 % and 32.4% for AA and WE subjects, respectively. Model predictions are consistent with clinical observations indicating higher glaucoma prevalence and severity in older individuals and in specific population groups, and strengthen the view of glaucoma as a multifactorial neurodegenerative disease in which metabolic vulnerability may represent one contributing pathway.
Sacco et al. (2026) studied this question.